Target intelligence / Profile preview

Ribonucleotide reductase subunit R1 (None)

Target
None
Molecular classification
Enzyme
01

Overview

Ribonucleotide reductase subunit R1 is a critical component of ribonucleotide reductase (RNR), an essential enzyme responsible for the de novo synthesis of deoxyribonucleotides from ribonucleotides. This reaction provides the building blocks required for DNA synthesis and repair, making RNR indispensable for cell proliferation and survival. It catalyzes the reduction of ribonucleoside diphosphates (NDPs) to their corresponding deoxyribonucleoside diphosphates (dNDPs), which are then further phosphorylated to form dNTPs, the direct precursors for DNA synthesis. Plays a key regulatory role in maintaining balanced dNTP pools within cells, ensuring high fidelity during DNA replication and repair processes. The activity of RNR is tightly regulated throughout the cell cycle to match cellular demands for DNA synthesis. Overexpression or dysregulation is associated with cancer progression. It serves as an established target for anticancer drugs such as hydroxyurea and gemcitabine that inhibit its function directly or indirectly.

Other names
R1 subunit of ribonucleotide reductaseLarge subunit of ribonucleotide reductaseRRM1
02

Mechanism of action

Inhibition of ribonucleotide reductase activity, leading to depletion of dNTPs and inhibition of DNA synthesis

03

Biological functions

Deoxyribonucleotide synthesisDNA synthesisDNA repairRegulation of dNTP poolsCell proliferation
04

Disease associations

Cancer
05

Safety considerations

MyelosuppressionImmunosuppression
06

Interacting drugs

Hydroxyurea

1 more in the full profile.

Beyond the preview

Go deeper on Ribonucleotide reductase subunit R1 (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribonucleotide reductase subunit R1 (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call